Welcome to Skilled in the Art. I’m Law.com IP reporter Scott Graham. As the world searches for vaccines, treatments and diagnostics for COVID-19, I’m hearing a lot of questions about the role of patents. Are they getting in the way of solutions? Inspiring them? Can the government commandeer patented technology if it’s in the national interest? Drs. Jonas Salk and Albert Sabin famously passed on the opportunity to patent their polio vaccines (though there’s some debate today as to the patentability of the Salk vaccine). Is it conceivable that a COVID-19 breakthrough would likewise be gifted to the public? I’m convening a roundtable of IP experts to address these questions. In keeping with the times, we’re doing it virtually.

As always, you can email me your feedback and follow me on Twitter.

Dr. Jonas Salk (Photo: SAS)

Q&A: Do Patents Have a Place With COVID-19?

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]